Urologic oncology seminars and original investigations impact factor

Aim and Scope

Urologic Oncology: Seminars And Original Investigations is a research journal that publishes research related to Urology. This journal is published by Elsevier. The P-ISSN of this journal is 10781439.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of Urologic Oncology: Seminars and Original Investigations.

Urologic Oncology: Seminars And Original Investigations Ranking

SJR (SCImago Journal Rank): 1.15

Quartile: Q1

Cite Score: 4.7

SNIP: 1.04

The SJR (SCImago Journal Rank) measures citations weighted by prestige. It is useful for comparing journals within the same field, and forms the basis of the subject category ranking. A journal SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige. SJR is developed by the Scimago Lab, originated from a research group at University of Granada. Q1 journals are cited more often and by more prestigious journals than those in the other quartiles.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

CiteScore of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal. This journal evaluation metric was launched in December 2016 by Elsevier as an alternative to the generally used JCR impact factors (calculated by Clarivate). CiteScore is based on the citations recorded in the Scopus database rather than in JCR, and those citations are collected for articles published in the preceding four years instead of two or five.

Source Normalized Impact per Paper (SNIP) is calculated annually from Scopus data. It is a sophisticated metric that intrinsically accounts for field-specific differences in citation practices.

Important Metrics

Urologic Oncology: Seminars and Original Investigations Indexing

The Urologic Oncology: Seminars and Original Investigations is indexed in:

• UGC CARE
• Scopus

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Urologic Oncology: Seminars And Original Investigations Quartile

The latest Quartile of Urologic Oncology: Seminars and Original Investigations is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Urologic Oncology: Seminars And Original Investigations?

This journal covers the fields/ categories related to Urology. If your research field is related to Urology, then visit the official website of Urologic Oncology: Seminars and Original Investigations and send your manuscript.

Tips for publishing in Urologic Oncology: Seminars And Original Investigations:Selection of research problem.Presenting a solution.Designing the paper.Make your manuscript publication worthy.Write an effective results section.Mind your references.

Acceptance Rate

Journal Review Time

Journals usually ask reviewers to provide their reviews within 3-4 weeks. However, few journals have a mechanism to enforce the deadline, which is why it can be hard to predict how long the peer review process will take.

The review time also depends upon the quality of a research paper.

Final Summary

• It is published by Elsevier.
• The journal is indexed in UGC CARE, Scopus.
• The (SJR) SCImago Journal Rank is 1.15.
• The Urologic Oncology: Seminars and Original Investigations is a reputed research journal.

Sources: